Aging, disability and frailty

Area of Science:

• Gerontology
• Geriatric Medicine
• Clinical Medicine

Background:

• Frailty is a common geriatric syndrome in individuals over 75, affecting 20-30% of this population.
• It signifies global impairment of physiological reserves across multiple organ systems, increasing vulnerability to stressors.
• Frailty is distinct from disability but associated with adverse outcomes like dependency, hospitalization, and mortality.

Purpose of the Study:

• To define the geriatric syndrome of frailty and its clinical manifestations.
• To explore the association of frailty with preclinical diagnoses and pathological laboratory markers.
• To discuss current recommendations for future research strategies in frailty syndrome.

Main Methods:

• Review of existing definitions and clinical correlates of frailty.
• Identification of the clinical phenotype of frailty, including multi-system pathologies.
• Analysis of associations between frailty and preclinical diagnoses (e.g., sarcopenia) and laboratory markers (e.g., IL-6, CRP).

Main Results:

• The clinical phenotype of frailty includes low physical activity, weakness, fatigability, slowness (especially gait), and weight loss.
• Preclinical diagnoses like sarcopenia, osteopenia, and deconditioning may underlie frailty symptoms.
• Pathological markers suggest frailty pathogenesis involves hormonal dysregulation, immuno-aging, and pro-inflammatory/pro-coagulation states.

Conclusions:

• Frailty is a complex geriatric syndrome with a distinct clinical phenotype and underlying pathological mechanisms.
• Understanding these mechanisms, including hormonal and inflammatory factors, is crucial for future research.
• Further research is recommended to develop effective strategies for managing frailty syndrome.